Proteomic analysis of CD4+ T-lymphocytes in patients with asthma between typical therapy (controlled) and no typical therapy (uncontrolled) level

Abstract

T-lymphocyte (T-LC)-derived cytokines have been implicated in asthmatic pathogenesis. Proteomic technology is now widely accepted as a complementary technology to genetic profiling. We investigated the changes of proteins in T-LC of asthmatic patients from the no typical therapy (uncontrolled) to typical therapy (controlled) level by using standard proteome technology. Methods: The proteins of CD4+ T-LC were isolated from the whole blood of six asthmatic patients from uncontrolled to controlled levels over 3 months. Two-dimensional polyacrylamide gel electrophoresis was performed and coomassie blue stained protein spots were comparatively analyzed by using an image analyzer. Some differentially expressed spots were identified by liquid chromatography/mass spectrometry and database search. Our results showed that 13 proteins showed different expression. Six protein spots in the CD4+ T-LC of the uncontrolled asthmatic patients were increased and 7 spots were decreased compared to those of the controlled subjects. In conclusion, the proteomic examination of the CD4+ T-LC revealed some differentially expressed proteins in the uncontrolled and controlled asthmatic patients. The possibility of using the differentially expressed proteins as important biomarkers and therapeutic targets warrants further study.

Keywords

asthma proteomics T-lymphocytes

References

Dunnill MS The pathology of asthma, with special reference to changes in the bronchial mucosa. J Clin Pathol 1960; 13: 27-33.

Bousquet J. , Chanez P. , Lacoste JY , et al. Eosinophilic inflammation in asthma. N Engl J Med 1990; 323: 1033-1039.

Laitinen A. , Laitinen LA Cellular infiltrates in asthma and in chronic obstructive pulmonary disease . Am Rev Respir Dis 1991; 143: 1159-1160; discussion 61.

Vignola AM , Chanez P. , Campbell AM , et al. Airway inflammation in mild intermittent and in persistent asthma . Am J Respir Crit Care Med 1998; 157: 403-409.

Wardlaw AJ , Dunnette S. , Gleich GJ , Collins JV , and Kay AB Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am Rev Respir Dis 1988; 137: 62-69.

Robinson DS , Hamid Q. , Ying S. , et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992; 326: 298-304.

The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. European Network for Understanding Mechanisms of Severe Asthma. Eur Respir J 2003; 22: 470-477.

Bian T. , Yin KS , Jin SX , et al. Treatment of allergic airway inflammation and hyperresponsiveness by imiquimod modulating transcription factors T-bet and GATA-3. Chin Med J (Engl) 2006; 119: 640-648.

Busse WW , Lemanske RF Jr. Asthma. N Engl J Med 2001; 344: 350-362.

10.

Kim JO , Kim DH , Chang WS , et al. Asthma is induced by intranasal coadministration of allergen and natural killer T-cell ligand in a mouse model. J Allergy Clin Immunol 2004; 114: 1332-1338.

11.

Seroogy CM , Gern JE The role of T regulatory cells in asthma. J Allergy Clin Immunol 2005; 116: 996-999.

12.

Nair KS , Jaleel A. , Asmann YW , Short KR , and Raghavakaimal S. Proteomic research: potential opportunities for clinical and physiological investigators. Am J Physiol Endocrinol Metab 2004; 286: E863-E874.

13.

Roh GS , Shin Y. , Seo SW , et al. Proteome analysis of differential protein expression in allergen-induced asthmatic mice lung after dexamethasone treatment. Proteomics 2004; 4: 3318-3327.

14.

Fajardo I. , Svensson L. , Bucht A. , and Pejler G. Increased levels of hypoxia-sensitive proteins in allergic airway inflammation . Am J Respir Crit Care Med 2004; 170: 477-484.

15.

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis 1987; 136: 225-244.

16.

Bateman ED , Hurd SS , Barnes PJ , et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31: 143-178.

17.

Jeong HC , Lee SY , Lee EJ , et al. Proteomic analysis of peripheral T-lymphocytes in patients with asthma. Chest 2007; 132: 489-496.

18.

Shingai R. , Maeda T. , Onishi S. , and Yamamoto Y. Autoantibody against 70 kD heat shock protein in patients with autoimmune liver diseases. J Hepatol 1995; 23: 382-390.

19.

Aron Y. , Busson M. , Polla BS , et al. Analysis of hsp70 gene polymorphism in allergic asthma. Allergy 1999; 54: 165-170.

20.

Tong W. , Luo W. Heat shock proteins’ mRNA expression in asthma. Respirology 2000; 5: 227-230.

21.

Qian X. , Zhu Y. , Xu W. , and Lin Y. Glucocorticoid receptor and heat shock protein 90 in peripheral blood mononuclear cells from asthmatics. Chin Med J (Engl ) 2001; 114: 1051-1054.

22.

Yano M. , Nakamuta S. , Wu X. , Okumura Y. , and Kido H. A novel function of 14-3-3 protein: 14-3-3zeta is a heat-shock-related molecular chaperone that dissolves thermal-aggregated proteins. Mol Biol Cell 2006; 17: 4769-4779.

23.

Katsumoto T. , Mitsushima A. , and Kurimura T. The role of the vimentin intermediate filaments in rat 3Y1 cells elucidated by immunoelectron microscopy and computer-graphic reconstruction. Biol Cell 1990; 68: 139-146.

24.

Blatti SP , Foster DN , Ranganathan G. , Moses HL , and Getz MJ Induction of fibronectin gene transcription and mRNA is a primary response to growth-factor stimulation of AKR-2B cells. Proc Natl Acad Sci U S A 1988; 85: 1119-1123.

25.

Haidaris PJ Induction of fibrinogen biosynthesis and secretion from cultured pulmonary epithelial cells. Blood 1997; 89: 873-882.

26.

Seeger W. , Stohr G. , Wolf HR , and Neuhof H. Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer. J Appl Physiol 1985; 58: 326-338.

27.

Wagers SS , Norton RJ , Rinaldi LM , Bates JH , Sobel BE , and Irvin CG Extravascular fibrin, plasminogen activator, plasminogen activator inhibitors, and airway hyperresponsiveness. J Clin Invest 2004; 114: 104-111.

28.

Pancholi V. Multifunctional alpha-enolase: its role in diseases . Cell Mol Life Sci 2001; 58: 902-920.

29.

Nahm DH , Lee KH , Shin JY , Ye YM , Kang Y. , and Park HS Identification of alpha-enolase as an autoantigen associated with severe asthma . J Allergy Clin Immunol 2006; 118: 376-381.

30.

Sanchez-Font MF , Sebastia J. , Sanfeliu C. , Cristòfol R. , Marfany G. , and Gonzàlez-Duarte R. Peroxiredoxin 2 (PRDX2), an antioxidant enzyme, is under-expressed in Down syndrome fetal brains. Cell Mol Life Sci 2003 ; 60: 1513-1523.

31.

Rautajoki KJ , Marttila EM , Nyman TA , and Lahesmaa R. Interleukin-4 inhibits caspase-3 by regulating several proteins in the Fas pathway during initial stages of human T helper 2 cell differentiation. Mol Cell Proteomics 2007; 6: 238-251.

32.

Friedemann J. , Grosse F. , and Zhang S. Nuclear DNA helicase II (RNA helicase A) interacts with Werner syndrome helicase and stimulates its exonuclease activity. J Biol Chem 2005; 280: 31303-31313.

33.

Valineva T. , Yang J. , and Silvennoinen O. Characterization of RNA helicase A as component of STAT6-dependent enhanceosome . Nucleic Acids Res 2006; 34: 3938-3946.

34.

Smillie LB Preparation and identification of alpha-and beta-tropomyosins. Methods Enzymol 1982; 85: 234-241.

35.

Aki T. , Kodama T. , Fujikawa A. , et al. Immunochemical characterization of recombinant and native tropomyosins as a new allergen from the house dust mite, Dermatophagoides farinae. J Allergy Clin Immunol 1995; 96: 74-83.

36.

Totary-Jain H. , Naveh- Many T. , Riahi Y. , Kaiser N. , Eckel J. , and Sasson S. Calreticulin destabilizes glucose transporter-1 mRNA in vascular endothelial and smooth muscle cells under high-glucose conditions . Circ Res 2005; 97: 1001-1008.